Impact of Surgical Intervention in Patients With Macrolide-Resistant Mycobacterium avium Complex Pulmonary Disease: A Multicentre Study
European Journal of Cardio-Thoracic Surgery · 2026
DOI: 10.1093/ejcts/ezag004 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2026. Verfasst von Shota Nakamura und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Drug Resistance, Bacterial, Lung Diseases, Macrolides. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
Treatment for patients with macrolide-resistant Mycobacterium avium complex (MR-MAC) pulmonary disease is a major clinical challenge, as pharmacologic options are limited and outcomes with antibiotics alone are unsatisfactory. Although surgical intervention has been considered in selected cases, clinical evidence specific to MR-MAC is limited. This study aimed to compare the clinical outcomes of surgical intervention for MR-MAC pulmonary disease to those of non-resistant cases.
Methods
This multicentre study included 248 patients who underwent pulmonary resection for MAC pulmonary disease. Among them, 34 patients (13.7%) had MR-MAC, which was defined as isolates with a clarithromycin minimum inhibitory concentration of ≥32 mg/L. Clinical outcomes were compared between the MR-MAC and non-MR-MAC groups. A multivariable analysis was conducted to identify risk factors for infectious relapse.
Results
In the MR-MAC and non-MR-MAC groups, the 5-year overall survival, 5-year relapse-free survival and postoperative complication rates were 100% and 98.5%, 85.4% and 67.9%, and 8.8% and 11.9%, respectively (P = .72, .47, and .78, respectively). Multivariable analysis revealed older age and lack of amikacin use as independent risk factors for infectious relapse, but not macrolide resistance.
Conclusions
Surgical resection is a viable and safe therapeutic option for selected patients with MR-MAC pulmonary disease, with long-term infection control comparable to that of non-MR-MAC cases. These findings support early surgical intervention in carefully selected patients with localized destructive lesions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
- Department of Thoracic Surgery, Daido Hospital, Nagoya, 457-8511, Japan.
- Data Coordinating Center, Department of Advanced Medicine, Nagoya University Hospital, Nagoya, 466-8560, Japan.
- Department of Thoracic Surgery, NHO Nagoya Medical Center, Nagoya, 460-0001, Japan.
- Department of Respiratory Medicine, NHO Higashinagoya National Hospital, Nagoya, 465-8620, Japan.
- Department of Thoracic Surgery, NHO Higashinagoya National Hospital, Nagoya, 465-8620, Japan.
ORCID-Profile: Shota Nakamura, Taku Nakagawa, Toyofumi Fengshi Chen-Yoshikawa
Zitieren
APA
Nakamura, S., Kinoshita, F., Seki, Y., Tsunoda, Y., Hayashi, Y., Nakagawa, T., Ogawa, K., Chen-Yoshikawa, T. F., & Yamada, K. (2026). Impact of Surgical Intervention in Patients With Macrolide-Resistant Mycobacterium avium Complex Pulmonary Disease: A Multicentre Study. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezag004
Vancouver
Nakamura S, Kinoshita F, Seki Y, Tsunoda Y, Hayashi Y, Nakagawa T, et al. Impact of Surgical Intervention in Patients With Macrolide-Resistant Mycobacterium avium Complex Pulmonary Disease: A Multicentre Study. European Journal of Cardio-Thoracic Surgery. 2026. doi:10.1093/ejcts/ezag004
BibTeX
@article{Nakamura2026,
author = {Nakamura, Shota and Kinoshita, Fumie and Seki, Yukio and Tsunoda, Yohei and Hayashi, Yuta and Nakagawa, Taku and Ogawa, Kenji and Chen-Yoshikawa, Toyofumi Fengshi and Yamada, Katsuo},
title = {Impact of Surgical Intervention in Patients With Macrolide-Resistant Mycobacterium avium Complex Pulmonary Disease: A Multicentre Study},
journal = {European Journal of Cardio-Thoracic Surgery},
year = {2026},
doi = {10.1093/ejcts/ezag004}
}
EUVIMED